FDA Approves Reblozyl (luspatercept-aamt) for the Treatment of Anemia in Adults With Beta Thalassemia Who Require Regular Red Blood Cell Transfusions

FDA Approves Reblozyl (luspatercept-aamt) for the Treatment of Anemia in Adults With Beta Thalassemia Who Require Regular Red Blood Cell Transfusions Print this page SUMMIT, N.J. & CAMBRIDGE, Mass.–(BUSINESS WIRE)– Celgene Corporation (NASDAQ: CELG) and Acceleron Pharma Inc. (NASDAQ: XLRN) today announced the U.S. Food and Drug Administration (FDA) has approved Reblozyl (luspatercept-aamt) for the… Read More »

Juul’s vaping products should be completely pulled off the market, says ex-FDA chief Gottlieb

Former FDA Commissioner Scott Gottlieb said Monday that Juul Labs’ products should be removed from the market, citing two studies that showed the scope of teen use of its e-cigarettes and flavored pods. “It’s very clear that Juul can’t keep their products out of the hands of kids,” said Gottlieb, a physician, health advocate and Pfizer board… Read More »